These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21044425)

  • 1. Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.
    Benedek TG
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S3-8. PubMed ID: 21044425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: a fascinating story.
    Malaviya AN
    Int J Rheum Dis; 2016 Sep; 19(9):844-51. PubMed ID: 27293066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials to establish methotrexate as a therapy for rheumatoid arthritis.
    Coury FF; Weinblatt ME
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S9-12. PubMed ID: 21044426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical overview of the treatment of rheumatoid arthritis with an emphasis on methotrexate.
    Kremer JM
    J Rheumatol Suppl; 1996 Mar; 44():34-7. PubMed ID: 8833049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
    Ruderman EM
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug combinations with methotrexate to treat rheumatoid arthritis.
    Rath T; Rubbert A
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S52-7. PubMed ID: 21044434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in use of methotrexate since the 1980s.
    Sokka T
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S13-20. PubMed ID: 21044427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.
    Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB
    Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis.
    Antoni C; Kalden JR
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S73-7. PubMed ID: 10589362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
    Boyce EG; Halilovic J; Stan-Ugbene O
    Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
    Punzi L; Lapadula G; Mathieu A
    BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
    Finckh A; Dehler S; Gabay C;
    Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
    St Clair EW; van der Heijde DM; Smolen JS; Maini RN; Bathon JM; Emery P; Keystone E; Schiff M; Kalden JR; Wang B; Dewoody K; Weiss R; Baker D;
    Arthritis Rheum; 2004 Nov; 50(11):3432-43. PubMed ID: 15529377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
    Kapetanovic MC; Saxne T; Nilsson JA; Geborek P
    Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of methotrexate in patients with ankylosing spondylitis.
    Haibel H; Sieper J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S128-31. PubMed ID: 21044446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.